Abstract: Managing data in a computing system comprising one or more cores includes: providing a cache in each of one or more of the cores that includes multiple storage locations; storing data of a first type of multiple types of data in a selected storage location of a first cache of a first core that is selected according to status information associated with the first cache, and updating the status information; and storing data of a second type of the multiple types of data in a storage location within a subset of fewer than all of the storage locations of the first cache and managing the status information to ensure that subsequent data of the second type received by the first core for storage in the first cache is stored in the storage location within the subset.

Abstract: A computing system comprises one or more cores. Each core comprises a processor. In some implementations, each processor is coupled to a communication network among the cores. In some implementations, a switch in each core includes switching circuitry to forward data received over data paths from other cores to the processor and to switches of other cores, and to forward data received from the processor to switches of other cores.

Abstract: Managing cache memories in a computing system comprising multiple cores includes: assigning home cache locations for portions of data stored among caches in a group of caches of respective cores; accessing a first one of the portions of the cached data by sending an access request to a first home core of that first one of the portions of cached data; tracking a history of access for the first one of the portions of cached data; determining whether the tracked history of access for the first one of the portions of cached data exceeds or meets a predetermined condition, and re-assigning a home cache location of the first one of the portions of cached data from the first home core to a second, different home core when the predetermined condition is met or exceeded.

Abstract: Managing data in a computing system comprising multiple cores includes: assigning a first set of data to caches within cores of a first subset of fewer than all of the cores in the computing system, and assigning a second set of data to caches within cores of a second subset of at least some remaining cores in the computing system not already assigned; and maintaining cache coherence among caches of respective cores in the first subset in response to data stored in at least one of the cores in the first subset being modified, and maintaining cache coherence among caches of respective cores in the second subset in response to data stored in at least one of the cores in the second subset being modified.

Abstract: In one embodiment of the present invention, a method includes generating a first order vector corresponding to a first entry in an operation order queue that corresponds to a first memory operation, and preventing a subsequent memory operation from completing until the first memory operation completes. In such a method, the operation order queue may be a load queue or a store queue, for example. Similarly, an order vector may be generated for an entry of a first operation order queue based on entries in a second operation order queue. Further, such an entry may include a field to identify an entry in the second operation order queue. A merge buffer may be coupled to the first operation order queue and produce a signal when all prior writes become visible.

Abstract: Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

Abstract: Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

Abstract: Modulators of PPAR&ggr; activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

Abstract: In accordance with the present invention, a structure of an asymmetric high-voltage MOS device is disclosed. The key aspect of the present invention is a high-voltage MOS device having a drift region underneath an isolation structure, wherein the high-voltage MOS device is isolated by shallow trench isolations and formed on a silicon-on-insulator (SOI) substrate. The asymmetric high-voltage MOS device comprises a substrate having an insulating layer thereon and a semiconductor layer of a first conductive type on the insulating layer. A plurality of shallow trench isolations defining an active area is formed in the semiconductor layer. A field oxide layer is formed in the active area of the semiconductor layer. A drift region of a second conductive type is formed under the field oxide layer in the semiconductor layer. A gate structure including a conductive layer and a gate dielectric layer is formed on the semiconductor layer in the active area and covers a portion of the field oxide layer.

Abstract: Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

Abstract: The present invention provides a method for making a HVMOS transistor on a SOI substrate. The method according to the present invention involves forming a plurality of shallow trench isolations (STI) and at least one active area isolated by each shallow trench isolation on the SOI substrate. Then, two unneighboring field oxide layers and a gate are formed on the surface of the active area, with a portion of the gate covering the two field oxide layers. Thereafter, two double diffuse drains(DDD) are formed on the surface of the active area not covered by the gate and the two field oxide layers. Finally, a drift region of the HVMOS transistor is formed at the bottom of the two field oxide layers.

Abstract: Modulators of PPAR&ggr; activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

Abstract: Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.

Abstract: Modulators of PPAR&ggr; activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

Abstract: Compounds and compositions are provided which are useful for the treatment of viral infections, particularly human Cytomegalovirus infection. The compounds include novel pyrimidine-based derivatives.